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Peptide maps obtained by reversed-phase HPLC of tryptic digests of isoelectric form 1 (pl= 6.5) and 2 (pl = 5.6) of chick- 
en egg white cystatin revealed that the difference was located only in a single peptide (residues Ser-74-Lys-91). Ser-80 
of cystatin 2 was subsequently identified as being modified by phosphorylation. Moreover, alkaline phosphatase treat- 
ment of a mixture of native cystatin forms. 1 and 2 was shown by ion-exchange chromatography to cause the disappear- 
ance ofisoetectric form 2 with a concomitant increase in form 1. Thus, the existence of two isoelectric forms of chicken 
cystatin is due to the phosphorylated form 2 and non-phosphorylated form 1. 
Cystatin; Proteinase inhibitor; Protein phosphorylation; (Chicken egg white) 
1. INTRODUCTION 
Chicken cystatin is a reversible, tight-binding 
protein inhibitor of papain-like cysteine pro- 
teinases. It has been crystallized [1] and its three- 
dimensional structure lucidated by X-ray diffrac- 
tion techniques [2]. Based on the crystal structure, 
a model for the interaction of chicken cystatin with 
papain has been proposed [2] and several proper- 
ties of the model confirmed by biochemical data 
[3]. 
By ion-exchange chromatography chicken 
cystatin can be resolved into two immunologically 
identical forms with pI values of 6.5 and 5.6 [4], 
designated as forms A and B [5] or 1 and 2 [4], 
respectively. The structural differences responsible 
for the occurrence of two isoelectric forms are a 
matter of controversy. Initially, it was proposed 
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that cystatin 1 is eight amino acid residues horter 
than cystatin 2 [5], but the separation of either 
form into full-length and N-terminally truncated 
forms contradicted these results [3]. Moreover, 
both full-length molecules had identical inhibition 
constants for papain and no sequence differences 
were detected between their 18 N-terminal amino 
acids [3]. Thus, as all previously published ata 
provided no explanation for the difference be- 
tween the forms, it was implicit hat the structures 
vary only to a small extent. 
Here, we show that the structural difference be- 
tween the two isoelectric forms of chicken cystatin 
is due to a phosphoserine r sidue in form 2. The 
location of the moiety in the polypeptide chain is 
identified and possible consequences of this 
modification are discussed. 
2. MATERIALS AND METHODS 
2.1. Materials 
Cystatin was purified from chicken egg white [5]. Forms 1 
and 2 were resolved by ion-exchange chromatography (Phar- 
macia Mono Q FPLC column) and further separated into the 
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Fig.1. Reversed-phase HPLC separation of tryptic peptides of cystatin form 1 (a), form 2 (b) and of a mixture of equal amounts of 
forms 1 and 2 (c). 
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Table 1 
Amino acid composition of peptides P-l 1 from cystatin 1 and 
2 in comparison with that deduced from the corresponding 
sequence of cystatin 1 [5,10] 
Amino acid Composition found for Composition 
peptide P-l 1 from from sequence 
Cystatin 1 Cystatin 2 
Asp/Asn 1.9 1.8 2 
Ser 2.9 2.5 3 
Glu/Gln 4.5 4.0 4 
G]Y 1.3 1.1 I 
Ala 1.3 1.0 1 
Met 0.7 0.8 1 
Leu 1.1 1.1 1 
Phe 0.8 0.9 1 
LYS 1.0 1.3 1 
His 0.9 0.8 1 
Pro f + 1 
CYS + + 1 
(+) Amino acid present but not quantified; Cys was determined 
as S-P-(4-pyridylethyl)cysteine 
full-length inhibitor and N-terminally truncated forms by 
hydrophobic-interaction chromatography [3]. Alkaline 
phosphatase from bovine intestine and TPCK-treated trypsin 
were from Sigma. Endoproteinases Glu-C and Asp-N were pur- 
chased from Boehringer. 
2.2. Peptide mapping 
N-terminally truncated cystatins 1 and 2 (peptide chain star- 
ting with Gly-9) were denatured, mercaptolysed and then 
alkylated with 4-vinylpyridine [a]. After digestion with trypsin 
5 10 15 20 25 
S-E-G-R-S-R-L-L-G-A-P-V-P-V-D-E-N-D-E_G-~-~-S-~-~- 
<_________________________ p-1 _________________________> <______ 
[4], fragments were separated on a Macherey-Nagel ET 250/8/4 
Nucleosil 300-10 C-18 HPLC column in an elution gradient 
from 0 (solvent A) to 80% acetonitrile (solvent B) in 0.1% TFA 
in 160 min. 
2.3. Endoproteolytic digestion 
Peptides were incubated at 37°C either for 2 h in 100~1 of 
0.1 M NHbHCOj (pH 7.8) with 5 pg endoproteinase Cm-C or 
for 16 h in 100~1 of 50 mM sodium phosphate buffer (pH 8.0) 
with 0.5 fig endoproteinase Asp-N and subsequently frac- 
tionated by HPLC. 
2.4. Alkaline phosphatase treatment 
Peptides were dissolved in 100 ~1 of 50 mM Tris-HCl, 1 mM 
MgS04, 0.1 mM ZnS04 (pH 9.0; P-buffer), incubated at 37°C 
for 1 h with 30 nkat (5.4,ug) alkaline phosphatase and subse- 
quently separated by HPLC. 0.58 mg native chicken cystatin 
was incubated at 37°C for 3.5 h in 0.23 ml P-buffer with 
30 nkat (5.4rg) alkaline phosphatase and separated on the 
Mono Q column. 
2.5. Amino acid and sequence analyses 
Amino acid analyses were carried out on a Biotronic LC 600 
amino acid analyzer after hydrolysis with 6 N HCl at 110°C for 
24 h or 2 h. Peptides were sequenced by Edman degradation in 
a prototype spinning-cup sequenator [7,8]. Phosphoamino acid 
analyses were performed by electrophoresis on cellulose thin- 
layer plates at pH 3.4 [9]. Additionally, the presence of 
phosphoserine was proved by amino acid analysis. 
3. RESULTS 
Peptide maps obtained by reversed-phase HPLC 
of tryptic digests of isoelectric forms 1 and 2 of 
chicken cystatin gave elution patterns which 
revealed only a single difference (fig.la,b). 
30 35 40 45 50 
*-P-A-"-A-E-Y-N-R-*-s-S-S-R-V_V-S-v-~-S-~~ 
-_________ p-2 __---------------> <_____ p-3 _____, <___ p-4 _-_, <- P-5 -, <_____ P-6 ____ 
55 60 65 70 75 
X-S-G-L-V-S-G-I-S-~-I-L-P-V-E-I-G-R-T_T-C-~-~-S-S- 
> <p-7> <_-______- 9-8 ------___-> <_______-_____ p-9 _____________, <----- p-10 ___-_> c______ 
80 85 90 95 100 
G-D-I-Q- S-C-E-P-H-Ll-E-P-E-"-A-K-Y-T-T-C-T-P-V_V-Y- ________________________ p-11 -----_______________-_________, <_________--_______________________ 
105 110 115 
S-I-P-W-I-N-*-I-K-L-=-S-s-S-C-* 
p-12 ----_______--_-____________> <_____ p-13 __-_> <P-14> 
Fig.2. Amino acid sequence of chicken cystatin 1 [5,10]. Peptides produced by trypsin digestion are indicated and numbered. 
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Chromatography of a mixture of equal amounts of 
these peptides unequivocally confirmed this result 
(fig. lc). Only the peptide eluting at about 22% sol- 
vent B split into two separate peaks, other peptides 
of the map being superimposable. Amino acid 
compositions of the two differing peptides (table 1) 
corresponded to tryptic peptide P-11 (fig.2), were 
identical and in agreement with the previously 
published sequence of cystatin 1 [5,10]. Thus, 
rather than an amino acid substitution either 
deamidation or a charged substituent could explain 
the two different cystatin forms. Deamidation 
would have changed Gln-79 (the only amide in 
P-l 1) to Glu and consequently introduced an addi- 
tional cleavage site for endoproteinase Glu-C, 
which specifically cleaves peptide bonds C- 
terminal to Glu residues [l 11. Incubation of P-l 1 
from cystatin 1 with endoproteinase Glu-C 
resulted in the formation of three fragments: S-S- 
G-D-L-Q-S-C-E, F-H-D-E-P-E and M-A-K. 
However, digestion of P-l 1 from cystatin 2 did not 
produce an additional fragment, thus constituting 
evidence against deamidation of Gln-79. Unex- 
pectedly, only two fragments were obtained: S-S- 
G-D-L-Q-S-C-E-F-H-D-E-P-E and M-A-K. 
Automatic sequence analysis of eight (form 1) 
and 15 (form 2) residues together with the amino 
acid compositions of tryptic and endoproteinase 
Glu-C digests gave S-S-G-D-L-Q-S-C-E-F-H-D-E- 
P-E-M-A-K as the complete sequence of P-l 1 from 
both cystatin forms (in agreement with the 
previously published sequence for residues 74-91 
of cystatin 1; fig.2). The reason for endoproteinase 
Glu-C failing to cleave the C-E bond in P-l 1 from 
cystatin 2 whilst complete cleavage was observed in 
P-11 from cystatin 1 could not be explained. 
Rechromatography of a mixture of equal 
amounts of isolated P-11 from the two cystatin 
forms clearly separated the peptides from each 
other (P-l 1 from cystatin 2 eluted first, indicating 
lower hydrophobicity). Treatment with alkaline 
phosphatase did not affect the retention time of 
P-11 from cystatin 1 but increased that of P-11 
from cystatin 2 to such an extent that it coeluted 
with P-11 from cystatin 1 (fig.3b). Thus, a 
phosphoamino acid in P-11 from cystatin 2 is the 
difference between the two cystatin forms. Fur- 
thermore, the phosphorylated residue must be 
phosphoserine, since neither threonine nor 
tyrosine, whose phosphorylated derivatives have 
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Fig.3. Reversed-phase HPLC separation of the untreated 
mixture of P-l 1 of cystatin form 1 and 2 (a) and of the alkaline 
phosphatase-treated mixture (b). 
also been found in proteins [12], occurs in P-l 1. 
To determine the exact location of the PSer- 
residue (position 74, 75 or 80) P-11 was treated 
with endoproteinase Asp-N, which specifically 
cleaves peptide bonds N-terminal to Asp residues 
[13]. Cleavage of P-l 1 from cystatin 1 gave the 
fragments S-S-G, D-E-P-E-M-A-K and D-L-Q-S- 
C-E-F-H. However, about 60% of the last frag- 
ment was unexpectedly cleaved further into D-L- 
Q-S-C and E-F-H (D-L-Q-S-C and D-E-P-E-M-A- 
K were not separated on the HPLC column). 
Cleavage of P-11 from cystatin 2 produced the 
fragments S-S-G, D-E-P-E-M-A-K and D-L-Q-S- 
165 
Volume 248, number 1,2 FEBS LETTERS May 1989 
OS 
- 0.2’ 
I 
% 
a 
0 
a b 
, I I 
10 20 O 
Volume (ml) 
Fig.4. Ion-exchange FPLC separation of the untreated mixture of native cystatin forms 1 and 2 (a) and of the alkaline phosphatase- 
treated mixture (b). 
C-E-F-H; no additional cleavage of the last frag- 
ment was observed. In both cases Ser-74 + Ser-75 
were present in a different fragment from that of 
Ser-80. 
For phosphoamino acid analysis both S-S-G 
fragments were hydrolyzed for 2 h - conditions 
which have been found to destroy PSer only to a 
minimal extent [ 141. No PSer was detected when 
the hydrolysates were subjected to amino acid 
analysis. The possibility of modification of Ser-74 
or Ser-75 of cystatin 2 by phosphorylation was 
thereby excluded. 
After partial acid hydrolysis the Ser-80- 
containing P-l 1 fragments, obtained by digestion 
with endoproteinase Asp-N, were subjected to 
thin-layer electrophoresis. Upon spraying with 
ninhydrin, a spot with relative mobility similar to 
that of authentic PSer was visible only in the sam- 
ple originating from cystatin 2. When the hydro- 
lysates were subjected to amino acid analysis, 
again only the sample originating from cystatin 2 
produced a peak at the position of authentic PSer. 
Thus, the two forms of chicken cystatin differ in 
166 
residue 80, which is serine in form 1 and 
phosphoserine in form 2. 
Ion-exchange chromatography of native chicken 
cystatin gave an average of about 63% form 1 and 
37% form 2, eluting at 70 and 140 mM KCl, 
respectively (fig.4a). Treatment of native cystatin 
with alkaline phosphatase for 3.5 h prior to 
separation by ion-exchange chromatography 
caused the disappearance of form 2 with a con- 
comitant increase in form 1 (fig.4b). After the 
3.5 h incubation period only 10% of the material 
eluted at the position of cystatin 2, whereas 90% 
eluted as form 1. Thus, about 75% of cystatin 2 
was transformed to cystatin 1 by alkaline 
phosphatase treatment, again indicating that a 
phosphorylated residue exists only in cystatin 2. 
4. DISCUSSION 
The present investigation has provided direct 
evidence for the occurrence of PSer at position 80 
in form 2 (Ser in form 1) and an explanation for 
Volume 248, number 1,2 FEBS LETTERS May 1989 
the difference between the two isoelectric forms of 
chicken cystatin. The additional negative charge of 
the PSer moiety is responsible for the lowering of 
the isoelectric point from 6.5 (form 1) to 5.6 (form 
2). Transformation of native cystatin 2 into 
cystatin 1 by phosphatase treatment confirmed 
that phosphorylation is the only difference be- 
tween both forms. 
According to the three-dimensional structure of 
cystatin 1 [2] the side chain of Ser-80 protrudes 
from the main body of the molecule (fig.5). Thus, 
the side chain is readily accessible to protein 
kinases as well as phosphatases, thereby explaining 
why the phosphomonoester linkage is rapidly 
hydrolyzed by alkaline phosphatase. 
Attempts to crystallize cystatin 2 for X-ray 
structure analysis were unsuccessful. The failure to 
obtain crystals may be due to the additional 
negative charge introduced by the PSer residue, 
which causes a significant increase in solubility. 
Additionally, if the crystal packing of cystatin 2 
were to be the same as that seen for cystatin 1, the 
negatively charged phosphoryl group of PSer-80 
would be in close vicinity to the negatively charged 
carboxyl group of Glu-65 of a symmetry-related 
molecule. The repulsion between these adjacent 
groups most likely hinders the formation of a 
highly ordered structure and thus prevents crystal 
growth. 
The amino acid sequence Ser-Cys-Glu at the 
phosphorylation site is in agreement with the con- 
sensus sequence PSer-X-Glu for phosphorylation 
sites of many other proteins [15-171. This se- 
quence (residues 80-82) is unique to chicken 
cystatin and has not been found in other members 
of family 1 and 2 of the cystatin superfamily [ 181. 
However, it has been detected in a family 3 
cystatin, human kininogen segment 3. Additional- 
ly, possible phosphorylation sites occur in human 
cystatins, e.g. S-V-E (residues 15-17) in cystatin 
C, and S-F-E (residues 96-98) in cystatins S and 
SN [18]. However, further investigations are re- 
quired to determine whether modification by 
phosphorylation also occurs in other cystatins. The 
recent report of glycosylated and non-glycosylated 
isoforms of rat cystatin structurally related to 
human cystatin C [19] indicates that post- 
translational modifications of cystatins may be 
more frequent than previously expected and may 
play an important role in their biological activities. 
Fig.5. a-Carbon drawing of the structure of chicken cystatin. Residues Gly-9, Leu-54, Ser-56 and Trp-104 (which undergo major 
binding interactions with papain [2]) and residues around the phosphorylation site (PSer-80-Glu-82) are represented with side chains 
(thick connections). 
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The biological function(s) of the phosphoryla- 
tion of cystatin 2 has remained unclear thus far. 
Nevertheless, regulation of the inhibitory activity 
seems quite unlikely as the two isoelectric forms 
have virtually identical inhibition constants for pa- 
pain [3]. This is in complete agreement with the 
proposed model of the cystatin-papain complex [2] 
as the PSer residue lies opposite to the cystatin- 
papain binding area (fig.5) and is not in contact 
with the proteinase molecule. Consequently, 
binding of cystatin to papain is not influenced by 
the PSer residue. However, the PSer moiety may 
possibly be involved in the import of cystatin into 
the developing egg. Thus, it is known that 
dephosphorylation of riboflavin-binding protein (a 
phosphoglycoprotein necessary for the transport 
of riboflavin to the egg) greatly diminishes the up- 
take of this protein into oocytes [20]. Furthermore, 
since peptide P-II from phosphorylated form 2 
has been found to be less susceptible to en- 
doproteolytic attack than P-l 1 from cystatin 1, the 
PSer moiety may protect the molecule against 
degradation. 
Cystatin isolated from chicken egg white is a 
mixture of the non-phosphorylated and 
phosphorylated form. This raises the question as 
to whether both forms occur naturally or one is 
formed from the other during storage of eggs or 
the purification. It is known that PSer in peptides 
and proteins is rapidly destroyed by &elimination 
of the phosphate residue when exposed to alkaline 
conditions [21,22]. Therefore, a certain amount of 
form 2 may be destroyed during the purification, 
which involves strongly alkaline conditions [5]. 
Additionally, cystatin 2 may be dephosphorylated 
in the egg, especially by the action of alkaline 
phosphatases, since the pH of chicken egg white is 
known to rise to 9.5 during storage [23]. Thus, it 
is quite uncertain as to whether the relative 
amounts of forms 1 and 2 found after the purifica- 
tion procedures reflect the in vivo situation. Fur- 
thermore, since chicken cystatin is not present 
exclusively in egg white but has also been detected 
in the serum and in muscle cells [4,24], variable 
amounts of the two isoelectric forms may be pre- 
sent in different tissues. 
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